DexCom ( DXCM -2.62%) is not a stock that investors should be rushing to sell. It has a few different opportunities to ...
With the company's market cap of $28 billion today, it's important to recognize that DexCom (NASDAQ: DXCM) is already one of ...
Shares of DexCom Inc. DXCM slipped 1.49% to $68.66 Tuesday, on what proved to be an all-around favorable trading session for ...
More than a decade after coining “Treat Yo’ Self Day” in her role as Donna on “Parks & Recreation,” Retta is once again ...
As a leading CGM maker, DexCom is likely to play a significant role in diabetes care for years, possibly decades. Given all ...
Dexcom unveiled its Dexcom G7 continuous glucose monitoring (CGM) for people with diabetes age two years and older in ...
In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Dexcom (DXCM – Research Report), with a ...
NDAQ:DXCM) Shareholders Are Invited To Join The Schall Law Firm In A Case Against DexCom, Inc. For Violating Securities Laws ...
DexCom's revised FY24 sales guidance in the Q2 earnings call led to a $18bn valuation reset. Read why I think DXCM stock is a ...
Shelomi Sanders, the daughter of Colorado Football head coach Deion Sanders, goes in-depth with Natalie Esquire and ...
New York, New York-- (Newsfile Corp. - September 22, 2024) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DexCom, Inc. (NASDAQ: DXCM) between January 8, ...
Shares of DexCom Inc. DXCM slipped 1.04% to $69.70 Monday, on what proved to be an all-around positive trading session for ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback